Consider Alternative Formulations In some cases, switching to non-oral formulations can bypass absorption challenges
First came GLP-1 receptor agonists, then dual agonists targeting two hormonal axes, and now GLP-3s like retatrutide
Patients with type 2 diabetes and obesity represent another population who may derive metabolic advantages, though it is important to note that Zepbound is not FDA-approved for diabetes treatment (tirzepatide is marketed as Mounjaro for diabetes management)
For long-term storage (months), keep it in the freezer
Quick Answer: While taking Zepbound, patients should avoid high-fat and greasy foods, certain medication combinations (especially other GLP-1 agonists and weight-loss products), excessive alcohol, and extreme caloric restriction to optimize treatment safety and effectiveness